182 related articles for article (PubMed ID: 23891978)
1. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection.
Sourisseau M; Goldman O; He W; Gori JL; Kiem HP; Gouon-Evans V; Evans MJ
Gastroenterology; 2013 Nov; 145(5):966-969.e7. PubMed ID: 23891978
[TBL] [Abstract][Full Text] [Related]
2. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
[TBL] [Abstract][Full Text] [Related]
3. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cells (iPSCs) in the modeling of hepatitis C virus infection.
Cheng L; Zhang Y; Nan Y; Qiao L
Curr Stem Cell Res Ther; 2015; 10(3):216-9. PubMed ID: 25248675
[TBL] [Abstract][Full Text] [Related]
5. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.
Ploss A; Evans MJ; Gaysinskaya VA; Panis M; You H; de Jong YP; Rice CM
Nature; 2009 Feb; 457(7231):882-6. PubMed ID: 19182773
[TBL] [Abstract][Full Text] [Related]
6. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
[TBL] [Abstract][Full Text] [Related]
7. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
[TBL] [Abstract][Full Text] [Related]
8. Tree shrew bone marrow-derived mesenchymal stem cells express CD81, OCLN, and miR-122, facilitating the entire hepatitis C virus life cycle.
Lu C; Feng Y; Sun X; Li N; Kuang D; Wang W; Tong P; Han Y; Xia X; Dai J
J Med Virol; 2020 Dec; 92(12):3465-3474. PubMed ID: 32056224
[TBL] [Abstract][Full Text] [Related]
9. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection.
Yoshida T; Takayama K; Kondoh M; Sakurai F; Tani H; Sakamoto N; Matsuura Y; Mizuguchi H; Yagi K
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):119-24. PubMed ID: 22093821
[TBL] [Abstract][Full Text] [Related]
10. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation.
Wu X; Robotham JM; Lee E; Dalton S; Kneteman NM; Gilbert DM; Tang H
PLoS Pathog; 2012; 8(4):e1002617. PubMed ID: 22496645
[TBL] [Abstract][Full Text] [Related]
11. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.
Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N
Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950
[TBL] [Abstract][Full Text] [Related]
12. Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes.
Schöbel A; Rösch K; Herker E
Sci Rep; 2018 Mar; 8(1):3893. PubMed ID: 29497123
[TBL] [Abstract][Full Text] [Related]
13. MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
Sendi H; Mehrab-Mohseni M; Foureau DM; Ghosh S; Walling TL; Steuerwald N; Zamor PJ; Kaplan KJ; Jacobs C; Ahrens WA; Russo MW; Clemens MG; Schrum LW; Bonkovsky HL
Liver Int; 2015 Apr; 35(4):1315-23. PubMed ID: 25302477
[TBL] [Abstract][Full Text] [Related]
14. Human embryonic stem cell-derived hepatoblasts are an optimal lineage stage for hepatitis C virus infection.
Yan F; Wang Y; Zhang W; Chang M; He Z; Xu J; Shang C; Chen T; Liu J; Wang X; Pei X; Wang Y
Hepatology; 2017 Sep; 66(3):717-735. PubMed ID: 28236326
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection of neuroepithelioma cell lines.
Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus utilizes VLDLR as a novel entry pathway.
Ujino S; Nishitsuji H; Hishiki T; Sugiyama K; Takaku H; Shimotohno K
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):188-93. PubMed ID: 26699506
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection and tight junction proteins: The ties that bind.
Mailly L; Baumert TF
Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183296. PubMed ID: 32268133
[TBL] [Abstract][Full Text] [Related]
18. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
[TBL] [Abstract][Full Text] [Related]
19. Generation of infectious HCV pseudo typed particles and its utilization for studying the role of CD81 & SRBI receptors in HCV infection.
Rafique S; Idrees M; Ali A; Sahibzada KI; Iqbal M
Mol Biol Rep; 2014 Jun; 41(6):3813-9. PubMed ID: 24549717
[TBL] [Abstract][Full Text] [Related]
20. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.
Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ
PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
